ConMed Corporation To Present At The 33rd Annual J.P. Morgan Healthcare Conference

UTICA, NY--(Marketwired - December 11, 2014) - CONMED Corporation (NASDAQ: CNMD), a medical technology company specializing in medical devices for orthopedic and general surgery, announced today that the Company will participate in the 33rd Annual J.P. Morgan Healthcare Conference on Wednesday, January 14, 2015 at 8:30 AM Pacific Time. The event will be held in San Francisco at the Westin St. Francis Hotel.

Mr. Curt Hartman, President and Chief Executive Officer of CONMED, will discuss the Company’s business. He will be joined by Rob Shallish, EVP Finance & CFO, and Luke Pomilio, EVP Controller & Corporate General Manager. The live webcast of CONMED’s presentation will be available at www.conmed.com in the Investors section of the website and will be available for replay through February 15, 2015.

About CONMED

CONMED is a medical technology company with an emphasis on surgical devices and equipment for minimally invasive procedures. Headquartered in Utica, New York, the Company’s 3,600 employees distribute its products worldwide with a direct selling presence in 16 countries outside the United States. International sales constitute approximately 50% of the Company’s revenues.

Forward Looking Information

Certain statements made in the presentation may contain forward-looking statements based on certain assumptions and contingencies that involve risks and uncertainties. The forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 and relate to the Company’s performance on a going-forward basis. The forward-looking statements in the presentation involve risks and uncertainties which could cause actual results, performance or trends, to differ materially from those expressed in the forward-looking statements or in previous disclosures. In addition to general industry and economic conditions, factors that could cause actual results to differ materially from those discussed in the forward-looking statements include, but are not limited to the risks relating to forward-looking statements discussed in the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2013.